Transvenous Right Greater Splanchnic Nerve Ablation in Heart Failure and Preserved Ejection Fraction: First-in-Human Study (JACC Heart Failure October 2022)

Transvenous Right Greater Splanchnic Nerve Ablation in Heart Failure and Preserved Ejection Fraction: First-in-Human Study (JACC Heart Failure October 2022) is organized by American College of Cardiology (ACC).,Date of Release: September 26, 2022,Term of Approval/Date of CME/MOC/ECME Expiration: September 25, 2023,Description:,Ablation of the right-sided greater splanchnic nerve (GSN) can reduce excessive splanchnic vasoconstriction, potentially improving the handling of volume shifts in patients with heart failure with preserved ejection fraction (HFpEF).